Tuts ,I am way out of my depth here,would you not think a deal somewhat similar to the Merck,Seattle Genetics agreements be reasonable to progress EfTi more rapidly.
Off the top of my head,I think the deal size was 4.5bfor there phase 2 drug.It consisted of .600 million upfront 1b equity stake up front at a good premium to market.About 2.6b in development milestones and sales milestones.And excusiivity still retained by Seattle Genetics in some countries.
As I said I’m way out of my depth and i may have misinterpreted some details in the agreement above ,but you get my drift .
Media, page-74
-
- There are more pages in this discussion • 670 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
0.010(2.70%) |
Mkt cap ! $559.2M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 39.0¢ | 37.0¢ | $864.8K | 2.267M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 38893 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.5¢ | 122026 | 27 |
View Market Depth
| Last trade - 12.23pm 28/08/2024 (20 minute delay) ? |
| IMM (ASX) Chart |